All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-30989237

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30989237	D67N	RT	gag-pol	HIV Infections	D G R L	View
2	30989237	E157Q	IN	gag-pol	HIV Infections	D G R L	View
3	30989237	G190A	RT	gag-pol	HIV Infections	D G R L	View
4	30989237	I82A	PR	gag-pol	HIV Infections	D G R L	View
5	30989237	K103N	RT	gag-pol	HIV Infections	D G R L	View
6	30989237	K219E	RT	gag-pol	HIV Infections	D G R L	View
7	30989237	K70R	RT	gag-pol	HIV Infections	D G R L	View
8	30989237	L33F	PR	gag-pol	HIV Infections	D G R L	View
9	30989237	M184V	RT	gag-pol	HIV Infections	D G R L	View
10	30989237	M41L	RT	gag-pol	HIV Infections	D G R L	View
11	30989237	M46I	PR	gag-pol	HIV Infections	D G R L	View
12	30989237	T215F	RT	gag-pol	HIV Infections	D G R L	View
13	30989237	T215I	RT	gag-pol	HIV Infections	D G R L	View
14	30989237	T215Y	RT	gag-pol	HIV Infections	D G R L	View
15	30989237	T97A	IN	gag-pol	HIV Infections	D G R L	View
16	30989237	Y181C	RT	gag-pol	HIV Infections	D G R L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.